Возраст домена | 27 лет |
Дата окончания | Истек срок регистрации |
PR | 4 |
ИКС | |
Страниц в Google | 1 |
Страниц в Яндексе | 0 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 19555761 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Optimize drug value | Drug and device commercialisation & outcomes
n/a
ICON Commercialisation & Outcomes delivers resources and expertise to identify, generate, synthesize and communicate evidence of treatment value and safety.
UTF-8
52.64 КБ
1 023
8 399 симв.
7 253 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
publicishealthcare.com | 11 | 4 |
10 | 965587 | 253219 | |
healthcarecomm.org | 10 | 4 |
0 | 1241489 | 46877 | |
healthcarecommunication.com | 10 | 6 |
0 | 1435380 | 674122 | |
linkedin.com | 10 | 9 |
0 | 25 | 10 | |
cisco.com | 9 | 8 |
0 | 763 | 414 | |
prsa.org | 8 | 6 |
30 | 106442 | 26062 | |
neshco.org | 8 | 3 |
0 | 3018310 | 596109 | |
cohealthcom.org | 8 | 4 |
0 | 7939479 | Нет данных | |
aachonline.org | 8 | 5 |
0 | 5275815 | Нет данных | |
strategichealthcare.com | 8 | 5 |
0 | 3673640 | Нет данных | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 30 Августа 2012 ) | |
Количество ссылок на сайт | 2 |
Количество доменов, которые ссылаются на сайт | 1 |
Количество найденных анкоров | 1 |
Исходящие (внешние) ссылки домена | 11 |
Количество доменов, на которые ссылается сайт | 7 |
Количество исходящих анкоров | 10 |
Внешние ссылки главной страницы ( 12 ) | |
webinars.iconplc.com/ | Webinar Channel |
investor.iconplc.com/ | Investors |
iconplc.com/services/clinical-research-services/site-and-pat... | Patients |
www2.iconplc.com/commercialisation_briefing_June2019 | Latest Briefing: ‘Medicare for All’ and the Implications for US Market Access Download our latest issue to explore insights, in... |
investor.iconplc.com/financials-filings/annual-reports | Results & Reports |
iconplc.com/study-volunteers | Volunteers |
investor.iconplc.com/ | Investors |
careers.iconplc.com/ | Jobs & Careers |
linkedin.com/company/icon-plc-2 | |
twitter.com/ICONplc | |
facebook.com/icon.plc.profile | |
youtube.com/user/ICONPlc | Youtube |
Внутренние ссылки главной страницы ( 95 ) | |
# | - |
/services/ | Services |
/services/adaptive-trials/ | Adaptive Trials |
/services/clinical-research-services/ | Clinical Research Services Integrated services that cover planning, management, execution and analysis. |
/services/consulting/ | Consulting |
/services/early-phase/ | Early Phase |
/services/functional-services-provision/ | Functional Services Provision |
/services/laboratories/ | Laboratories |
/services/language-services/ | Webpage Language Services |
/services/imaging/ | Medical Imaging |
/services/real-world-intelligence/ | Webpage Real World Intelligence |
/services/value-access-outcomes/ | Value Access Outcomes |
/services/clinical-research-services/site-and-patient-recrui... | Site & Patient Solutions Site and patient identification, enrolment and engagement. |
/sectors/ | Sectors |
/sectors/biosimilars/ | Biosimilars |
/sectors/biotech/ | Biotech |
/sectors/government-and-public-health-solutions/ | Government & Public Health Solutions |
/sectors/medical-device/ | Medical Device |
/sectors/pharma/ | Pharmaceuticals |
/sectors/medical-device/regulatory-affairs/eu-regulations_md... | EU MDR/IVDR Regulations The new EU medical and in vitro diagnostic device regulations go into effect at the start of 2020. Are y... |
/insights/value-based-healthcare/making-sense-of-the-biosimi... | Making sense of the Biosimilars market Strategies and recommendations to achieve optimal market access. |
/therapeutics/ | Therapeutics |
/therapeutics/cardiovascular/ | Cardiovascular |
/therapeutics/cell-and-gene-therapies/ | Cell and Gene Therapies |
/therapeutics/central-nervous-system/ | Central Nervous System |
/therapeutics/endocrine-metabolic-disorders/ | Endocrine & Metabolic Disorders |
/therapeutics/genomics/ | Genomics |
/therapeutics/infectious-diseases/ | Infectious Diseases |
/therapeutics/internal-medicine-and-immunology/ | Internal Medicine & Immunology |
/therapeutics/medical-device/ | Medical Device |
/therapeutics/ophthalmology/ | Ophthalmology |
/therapeutics/rare-and-orphan-diseases/ | Rare & Orphan Diseases |
/therapeutics/transplant-immunology/ | Transplant Immunology |
/therapeutics/womens-health/ | Women's Health |
/therapeutics/oncology/ | Oncology ICON has conducted hundreds of clinical studies in both solid and haematological tumours, including experience with CAR... |
/therapeutics/vaccines/ | Vaccines ICON has recently led the development of 14 vaccines resulting in FDA/EMA approvals. |
/innovation/ | Innovation |
/innovation/firecrest/ | FIRECREST |
/innovation/Intel-Pharma-Analytics/ | Intel Pharma Analytics Platform |
/innovation/drug-safety-reporting-solution/ | Drug Safety Reporting Solution |
/innovation/one-search/ | One Search |
/innovation/evidence-platform/ | Evidence Platform |
/innovation/flex-advantage/ | FLEX ADVANTAGE |
/innovation/imaging-technology/ | Medical Imaging Technology |
/innovation/nonmem/ | NONMEM |
/innovation/ICONIK/ | ICONIK |
/innovation/pdx-pop/ | PDx-POP |
/innovation/imra/ | IMRA |
/innovation/pubshub/ | PubsHub |
/innovation/addplan/ | ADDPLAN® Using data to design, simulate, and analyse adaptive clinical trials with ease. |
/innovation/patient-engagement-platform/ | Patient Engagement Portal Connecting patients with the right trial in the right location. |
/insights/ | Insights |
/insights/digital-disruption/ | Digital Disruption |
/insights/patient-centricity/ | Patient Centricity |
/insights/transforming-trials/ | Transforming Trials |
/insights/value-based-healthcare/ | Value Based Healthcare |
/insights/blog/ | Blog |
/insights/videos/ | Videos |
/insights/digital-disruption/mHealth-wearables/ | mHealth & Wearables Remote monitoring and leveraging wearable devices and sensors in clinical trials. |
/insights/digital-disruption/real-world-data/ | Real World Data Reduce post market study costs with Real World Data. |
/news-events/ | News & Events |
/news-events/press-releases/ | Press Releases |
/news-events/thought-leadership/ | In the News |
/news-events/events/ | Events |
/news-events/mediakit/ | Mediakit |
/news-events/social-media/ | ICON on social media |
/news-events/awards/ | Awards |
/news-events/events/webinars/improving-patient-adherence-wit... | Webinar: Gamification in Healthcare for Quality Data Collection 20 February, 2020 |
/news-events/events/webinars/using-historical-controls-in-ra... | Webinar: Using Historical Controls in Rare Disease Clinical Trials 12 March, 2020 |
/about/ | About ICON |
/about/company-history/ | Company History |
/about/icon-in-asia-pacific/ | ICON in Asia Pacific |
/about/icon-in-latin-america/ | ICON in Latin America |
/about/leadership/executive-management/ | Leadership |
/about/our-quality/ | Quality We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities. |
/about/icon-and-you/ | ICON and You Partners Making a Difference. |
/careers/ | Careers |
/investigators/ | Investigators |
/contact/ | Contact us |
index.xml?&Language=en | EN |
index.xml?&Language=ja | 日本語 |
/__uuid/86e65a88-d274-40a5-90b8-d833b98f902e/index.xml | Real World Evidence and Late Phase Research Correct study choice and effective execution are paramount to achieving your goals.... |
/__uuid/ae3c4494-9bba-45ea-b3c7-310823dc0958/ | Access, Commercialisation and Communications Our integrated team of 300+ industry experts provides life-science clients with st... |
/__uuid/77418dfd-f55b-4969-a10f-56ee90229362/ | Patient Centred Sciences Patients are at the heart of our research. We help pharma, device and biotechnology companies at every... |
/services/commercialisation-and-outcomes/real-world-intellig... | Real World Evidence Strategy and Analytics Our global epidemiologists and outcomes researchers employ Real World Intelligence, c... |
/__uuid/7c751ec6-05c8-4123-a28c-4f3fa93f5117/ | Late Phase Patient and Site Engagement We understand the unique requirements of managing late phase and post-market studies. Our... |
/__uuid/523d07f3-fdb0-47c1-9016-c2571336d867/ | Strategic Regulatory Services Today’s regulatory landscape is complex and ever-changing. We deliver solutions built on 30+ years... |
/__uuid/9a66003e-6e24-4a7c-9fb6-d49c89d0229e/ | Mapi Research Trust ICON is the leading sponsor of Mapi Research Trust, a non-profit organisation dedicated to improving patient... |
/services/value-access-outcomes/briefing/ | Briefing Commercialisation & Outcomes Briefing |
/disclaimer/ | Disclaimer |
/privacy/ | Privacy |
/site-cookies/ | Site Cookies |
/contact/submit-rfp/ | Submit proposal request |
/preferences/ | Update Email Preferences |
/contact/global-office-locator/ | Global office locator |
Domain Name: CHCINC.COM
Registry Domain ID: 138751_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2018-01-11T04:56:17Z
Creation Date: 1997-02-06T05:00:00Z
Registry Expiry Date: 2019-02-07T05:00:00Z
Registrar: Network Solutions, LLC.
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: BRIT.NS.CLOUDFLARE.COM
Name Server: CORY.NS.CLOUDFLARE.COM
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-09-25T05:39:07Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
Нидерланды - Амстердам - 168.100.10.110
Cloud 9 Internet
Cloud 9 Internet
HTTP/1.1 200 OK
Accept-Ranges: bytes
Cache-control: no-cache="set-cookie"
Content-Type: text/html; charset=UTF-8
Date: Sun, 02 Feb 2020 14:12:13 GMT
ETag: "d473277106ce85dcb081bd32a2d7f592"
Expires: Sat, 02 Feb 2019 08:12:13 GMT
Last-Modified: Sun, 02 Feb 2020 14:12:13 GMT
Server: Roxen
Set-Cookie: AWSELB=CB9DA3E70E32836717257EE63CF891E0239CAB8B072FA8159413B1E2D7BC5C23C70568FFC566FB90483A23D832E8505AACF3DD714AEE67A2157527E7A925CEDE3484EA3692;PATH=/
Vary: *
X-Frame-Options: deny
X-XSS-Protection: 1; mode = block
Content-Length: 53900
Connection: keep-alive
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"